Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis

Overview

Journal Appl Biochem Biotechnol

Specialties Biochemistry
Biotechnology

Date 2021 Aug 31

PMID 34463927

Citations 7

Authors

Saman Sargazi

Armin Zahedi Abghari

Hosna Sarani

Roghayeh Sheervalilou

Shekoufeh Mirinejad

Ramin Saravani

Ebrahim Eskandari

Affiliations

Soon will be listed here.

Abstract

Caspase-9 (CASP9) and caspase-10 (CASP10) polymorphisms were associated with human cancers; however, the results remain controversial. In this meta-analysis, we aimed to estimate the relationship among CASP9 (rs1052576, rs1052571, rs4645978, rs4645981, rs4645982, rs2308950) and CASP10 (rs13006529, rs13010627, rs3900115) polymorphisms and the overall risk of cancers. Relevant studies were obtained from Web of Science, MEDLINE, PubMed, Scopus, and Google scholar databases (updated January 1, 2021). Odds ratio (OR) and 95% confidence intervals (CIs) were measured to estimate the strength of association. Our meta-analysis included 40 studies. The rs4645981 significantly enhanced the risk of cancer under TT vs. CC (OR = 2.42), TC vs. CC (OR = 1.55), TT+ TC vs. CC (OR = 1.66), TT vs. TC + CC (OR = 1.91), and T vs. C (OR = 1.57) inheritance models. As for the rs1052571 variant, increased risk of cancer was observed under TT vs. CC (OR =1.22), TC vs. CC (OR = 1.17), and TT+ TC vs. CC (OR = 1.18) models. The stratified analysis showed a significant correlation between rs4645978 or rs4645981 polymorphisms and cancer risk, while in Asians rs4645978 conferred an increased risk of colorectal, lung, and prostate cancer. Both rs4645981 and rs1052576 polymorphisms were correlated with an enhanced risk of lung cancer. In conclusion, our meta-analysis suggested that CASP9 rs4645981 and rs1052571 polymorphisms are associated with overall cancer risk. More studies on larger populations are warranted to validate these associations.

Citing Articles

Synthesis, characterization, and evaluation of copper-doped zinc oxide nanoparticles anticancer effects: in vitro and in vivo experiments.

Ghaznavi H, Hajinezhad M, Hesari Z, Shirvaliloo M, Sargazi S, Shahraki S BMC Cancer. 2025; 25(1):37.

PMID: 39780079 PMC: 11707944. DOI: 10.1186/s12885-024-13398-w.

A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.

Zamani N, Szymiczek A, Shakeri R, Poustchi H, Pourshams A, Narod S PLoS One. 2023; 18(11):e0292611.

PMID: 37943872 PMC: 10635553. DOI: 10.1371/journal.pone.0292611.

Investigation of Genetic Factors and Clinical Data in Breast Cancer Highlights the Importance of Breastfeeding and Cancer History.

Merces A, da-Silva-Cruz R, Silva C, Burbano R, Ribeiro-Dos-Santos A, Cavalcante G Curr Issues Mol Biol. 2023; 45(10):7933-7943.

PMID: 37886944 PMC: 10605415. DOI: 10.3390/cimb45100501.

Assessment of the association of gene polymorphisms with the susceptibility of cervical cancer: A case-control study and meta-analysis.

Barek M, Basher M, Aziz M, Hossen M, Jahan N, Afroz N Heliyon. 2023; 9(7):e17712.

PMID: 37483787 PMC: 10359826. DOI: 10.1016/j.heliyon.2023.e17712.

Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis.

Yang M, Zhang M, Wang Q, Guo X, Geng P, Gu J BMC Cancer. 2023; 23(1):688.

PMID: 37480014 PMC: 10362596. DOI: 10.1186/s12885-023-11164-y.

References

Cao J, Yuan P, Abuduwufuer A, Lv W, Yang Y, Hu J . Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls. PLoS One. 2015; 10(6):e0128829. PMC: 4456375. DOI: 10.1371/journal.pone.0128829. View

Marahatta S, Sharma N, Koju R, Makaju R, Petmitr P, Petmitr S . Cancer: determinants and progression. Nepal Med Coll J. 2005; 7(1):65-71. View

Park J, Park J, Jang J, Choi J, Kim K, Cha S . Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet. 2006; 15(12):1963-71. DOI: 10.1093/hmg/ddl119. View

Qin Q, Zhang C, Zhu H, Yang X, Xu L, Liu J . Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies. J Cancer Res Clin Oncol. 2013; 140(2):179-88. DOI: 10.1007/s00432-013-1524-z. View

Hajra K, Liu J . Apoptosome dysfunction in human cancer. Apoptosis. 2004; 9(6):691-704. DOI: 10.1023/B:APPT.0000045786.98031.1d. View

Degterev A, Boyce M, Yuan J . A decade of caspases. Oncogene. 2003; 22(53):8543-67. DOI: 10.1038/sj.onc.1207107. View

Wilson N, Dixit V, Ashkenazi A . Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol. 2009; 10(4):348-55. DOI: 10.1038/ni.1714. View

Shen X, Wang C, Li Y, Wang L, Zhou B, Xu B . Downregulation of caspase-9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome. Colorectal Dis. 2009; 12(12):1213-8. DOI: 10.1111/j.1463-1318.2009.02009.x. View

Shen X, Wang C, Li Y, Zhou B, Xu B, Yang L . Downregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancer. Int J Colorectal Dis. 2011; 26(12):1519-24. DOI: 10.1007/s00384-011-1239-z. View

10.

Grenet J, Teitz T, Wei T, Valentine V, Kidd V . Structure and chromosome localization of the human CASP8 gene. Gene. 1999; 226(2):225-32. DOI: 10.1016/s0378-1119(98)00565-4. View

11.

Park W, Lee J, Shin M, Park J, Kim H, Lee J . Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene. 2002; 21(18):2919-25. DOI: 10.1038/sj.onc.1205394. View

12.

Allan L, Clarke P . Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J. 2009; 276(21):6063-73. DOI: 10.1111/j.1742-4658.2009.07330.x. View

13.

Liamarkopoulos E, Gazouli M, Aravantinos G, Tzanakis N, Theodoropoulos G, Rizos S . Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric Cancer. 2011; 14(4):317-21. DOI: 10.1007/s10120-011-0045-1. View

14.

Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, Wang S . Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis. 2006; 28(4):823-7. DOI: 10.1093/carcin/bgl196. View

15.

Lou Y, Fang C, Li J . [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007; 24(1):59-62. View

16.

Hosgood 3rd H, Baris D, Zhang Y, Zhu Y, Zheng T, Yeager M . Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol Oncol. 2008; 26(3):148-51. PMC: 2586415. DOI: 10.1002/hon.852. View

17.

Ulybina Y, Kuligina E, Mitiushkina N, Rozanov M, Ivantsov A, Ponomariova D . Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett. 2009; 278(2):183-191. DOI: 10.1016/j.canlet.2009.01.012. View

18.

Ulybina Y, Kuligina E, Mitiushkina N, Sherina N, Baholdin D, Voskresenskiy D . Distribution of coding apoptotic gene polymorphisms in women with extreme phenotypes of breast cancer predisposition and tolerance. Tumori. 2011; 97(2):248-51. DOI: 10.1177/030089161109700222. View

19.

Cingeetham A, Vuree S, Rao Dunna N, Gorre M, Nanchari S, Edathara P . Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects. Tumour Biol. 2014; 35(9):8813-22. DOI: 10.1007/s13277-014-2096-5. View

20.

Ozdogan S, Kafadar A, Yilmaz S, Timirci-Kahraman O, Gormus U, Isbir T . Role of Caspase-9 Gene Ex5+32 G>A (rs1052576) Variant in Susceptibility to Primary Brain Tumors. Anticancer Res. 2017; 37(9):4997-5000. DOI: 10.21873/anticanres.11912. View